The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture

Article Abstract:

The safety and efficacy of MK-0677, an orally active growth hormone (GH) secretagogue, on functional recovery from hip fracture in older adults are evaluated. Several points that need to be considered while using the GH secretagogue on the elderly patients are discussed.

Somatotropin

---

Estimating hip fracture morbidity, mortality and costs

Article Abstract:

The estimation of lifetime morbidity, mortality, and costs from hip fracture incorporated in the activities of daily life are determined. The results estimated from hip fractures in United States are discussed.

Morbidity

---

Agreement between patient and proxy responses of health-related quality of life after hip fracture

Article Abstract:

The adverse effects of hip fracture on quality of life of elderly patients are examined based on responses from patients and proxies during a 6-month recovery period from hip injury.

Analysis, Complications and side effects, Quality of life

Similar abstracts:

• Abstracts: What every woman should know about hormone replacement therapy. How to build better bones
• Abstracts: Diagnosis and treatment of osteoporosis in patients with vertebral compression fractures. Bone density testing in older women and its association with patient age
• Abstracts: Evaluation of Simulated Presence: a personalized approach to enhance well-being in persons with Alzheimer's disease
• Abstracts: Age-related deficits in guided search using cues. Age effects on social cognition: Faces tell a different story
• Abstracts: Age, skill, and contexual cuing in target detection. Instance-based automaticity and aging: Acquisition, reacquisition, and long-term retention

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.